VeriMom¿Es hypericum perforatum leaf extract seguro durante el embarazo?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
Pregnancy-safe products containing hypericum perforatum leaf extract
Related ingredients
Frequently asked questions
- ¿Es hypericum perforatum leaf extract seguro durante el embarazo?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
- ¿Es hypericum perforatum leaf extract seguro durante la lactancia?
- No regulatory harmonised reproductive/breastfeeding classification. While oral St. John's wort is known for systemic drug interactions and there are reports of transfer with systemic use, topical cosmetic use of the leaf extract is not established to cause significant transfer into breastmilk; therefore hazard and mechanism are scored 0 and exposure is low but measurable (e=1). Sources: PubMed (systemic use literature), CosIng, ECHA (no harmonised CLP).
- ¿Es hypericum perforatum leaf extract seguro para la piel del bebé?
- No evidence of a reproductive or developmental hazard specific to infants from topical exposure to Hypericum perforatum leaf extract; mechanism of reproductive toxicity is not demonstrated. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight, dermal exposure is increased relative to adults, so exposure is increased to moderate (adult e=1 → infant e=2). Note: phototoxic constituents (e.g., hypericin) may increase skin reaction risk but that is separate from reproductive classification. Sources: CosIng, PubMed (phototoxicity literature), ECHA (no harmonised CLP).
- ¿Cómo puntúa VeriMom a hypericum perforatum leaf extract?
- VeriMom puntúa hypericum perforatum leaf extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a hypericum perforatum leaf extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a hypericum perforatum leaf extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.